BELAIRA Trademark

Trademark Overview


On Thursday, April 14, 2016, a trademark application was filed for BELAIRA with the United States Patent and Trademark Office. The USPTO has given the BELAIRA trademark a serial number of 87001169. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 20, 2017. This trademark is owned by Glaxo Group Limited. The BELAIRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
belaira

General Information


Serial Number87001169
Word MarkBELAIRA
Filing DateThursday, April 14, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 20, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "BELAIRA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, November 20, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 20, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, January 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 7, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2016NON-FINAL ACTION E-MAILED
Thursday, July 7, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 5, 2016ASSIGNED TO EXAMINER
Tuesday, April 19, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 18, 2016NEW APPLICATION ENTERED IN TRAM